A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Recruiting

Phase 3

NerandomilastA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

Sponsor:

Boehringer Ingelheim

Code:

NCT07497087

Conditions

Systemic Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Placebo matching nerandomilast formulation 1

Placebo matching nerandomilast formulation 2

Nerandomilast formulation 1

Nerandomilast formulation 2

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-19. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2026-08-06.